Sutro Biopharma (STRO) — Net Asset Quality Index
Sutro Biopharma (STRO) has a Net Asset Quality Index of -41.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $209.66 Million minus total liabilities of $296.93 Million yields net assets of $-87.27 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Sutro Biopharma (STRO) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sutro Biopharma Net Asset Quality Index Over Time (2016–2024)
This chart shows how Sutro Biopharma's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the index stands at -41.6%, representing net assets of $-87.27 Million against total assets of $209.66 Million USD. See STRO working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Sutro Biopharma (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for Sutro Biopharma from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Sutro Biopharma (STRO) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 11.5% | $44.60 Million | $387.21 Million | $342.61 Million | ▼ -20.3 pp |
| 2023 | 31.8% | $149.65 Million | $470.74 Million | $321.09 Million | ▼ -21.5 pp |
| 2022 | 53.3% | $217.05 Million | $406.94 Million | $189.90 Million | ▼ -20.6 pp |
| 2021 | 74.0% | $252.56 Million | $341.41 Million | $88.84 Million | ▼ -10.3 pp |
| 2020 | 84.3% | $332.05 Million | $394.11 Million | $62.06 Million | ▲ +21.7 pp |
| 2019 | 62.5% | $97.79 Million | $156.37 Million | $58.58 Million | ▲ +3.6 pp |
| 2018 | 58.9% | $131.54 Million | $223.14 Million | $91.60 Million | ▲ +326.3 pp |
| 2017 | -267.4% | $-109.00 Million | $40.77 Million | $149.77 Million | ▼ -136.1 pp |
| 2016 | -131.2% | $-90.90 Million | $69.28 Million | $160.18 Million | — |